Nanoparticles Containing a Liver X Receptor Agonist Inhibit Inflammation and Atherosclerosis

Liver X receptor (LXR) signaling pathways regulate lipid metabolism and inflammation, which has generated widespread interest in developing synthetic LXR agonists as potential therapeutics for the management of atherosclerosis. In this study, we demonstrate that nanoparticles (NPs) containing the sy...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Adv Healthc Mater
Main Authors: Zhang, Xue-Qing, Even-Or, Orli, Xu, Xiaoyang, van Rosmalen, Mariska, Lim, Lucas, Gadde, Suresh, Farokhzad, Omid C., Fisher, Edward A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4527680/
https://ncbi.nlm.nih.gov/pubmed/25156796
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/adhm.201400337
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados